U.S. Medical Affairs Outsourcing Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Medical Affairs Outsourcing Market 

5.1. COVID-19 Landscape: US Medical Affairs Outsourcing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Medical Affairs Outsourcing Market, By Services

8.1. US Medical Affairs Outsourcing Market, by Services, 2024-2033

8.1.1. Medical Science Liaisons (MSLs)

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Medical Writing & Publishing

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Medical Monitoring

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Medical Information

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. US Medical Affairs Outsourcing Market, By Industry

9.1. US Medical Affairs Outsourcing Market, by Industry, 2024-2033

9.1.1. Pharmaceutical

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Biopharmaceutical

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Medical Devices

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Therapeutic Medical devices

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Diagnostic medical devices

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. US Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast

10.1. US

10.1.1. Market Revenue and Forecast, by Services (2021-2033)

10.1.2. Market Revenue and Forecast, by Industry (2021-2033)

Chapter 11. Company Profiles

11.1. Pharmaceutical Product Development, LLC

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. IQVIA Holdings Inc

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. SGS SA

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. ZEINCRO Group

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Pfizer Inc

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. The Medical Affairs Company

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. ICON plc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Ashfield Healthcare Communications

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Syneos Health Inc

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Wuxi Clinical Development, Inc

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms